Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Edwards CLASP TR EFS

NCT: NCT03745313 · COMPLETED

NCT IDNCT03745313
StatusCOMPLETED
Start Date2019-02-05
Completion2025-05-13
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

Early feasibility study to assess the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System in tricuspid regurgitation

Frequently Asked Questions

What is Edwards CLASP TR EFS?

Edwards CLASP TR EFS is a clinical trial registered under NCT03745313. Current status: COMPLETED.

What is the status of NCT03745313?

The current status of NCT03745313 (Edwards CLASP TR EFS) is: COMPLETED.

When did Edwards CLASP TR EFS start?

Edwards CLASP TR EFS started on 2019-02-05.

Related Devices

K251982Edwards MC3 Tricuspid annuloplasty ring (4900)Edwards Lifesciences, LLC PMA P220003Mitral valve repair devicesEdwards Lifesciences, LLC K152980Flo Trac sensor, Volume View sensorEdwards Lifesciences, LLC K153069Edwards Balloon CatheterEdwards Lifesciences K160084Swan Ganz CathetersEdwards Lifesciences, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑